Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 15,000 | 3,000 | 0 |
| Gross Profit | N/A | N/A | 15,000 | 3,000 | N/A |
| Operating Expenses | 24,336 | 22,635 | 25,253 | 25,258 | 33,745 |
| Operating Income | -24,336 | -22,635 | -10,253 | -22,258 | -33,745 |
| Interest Expense | 0 | 0 | 0 | 200 | 240 |
| Other Income | 569 | 1,087 | 1,991 | 2,173 | 2,901 |
| Pre-tax Income | -23,767 | -21,548 | -8,262 | -20,285 | -31,084 |
| Income Tax | N/A | N/A | N/A | -22 | -51 |
| Net Income Continuous | -23,767 | -21,548 | -8,262 | -20,263 | -31,033 |
| Net Income | $-23,767 | $-21,548 | $-8,262 | $-20,263 | $-31,033 |
| EPS Basic Total Ops | -0.87 | -0.79 | -0.30 | -0.74 | -1.15 |
| EPS Basic Continuous Ops | -0.87 | -0.79 | -0.30 | -0.75 | -1.15 |
| EPS Diluted Total Ops | -0.87 | -0.79 | -0.30 | -0.74 | -1.15 |
| EPS Diluted Continuous Ops | -0.87 | -0.79 | -0.30 | -0.75 | -1.15 |
| EBITDA(a) | $-23,823 | $-22,047 | $-10,121 | $-23,858 | $-33,610 |